Russia Approves Oncophage For Kidney Cancer Treatment

Armen Hareyan's picture
Advertisement

Antigenics Inc. (NASDAQ: AGEN) today announced that the Russian Ministry of Public Health has issued a registration certificate for the use of Oncophage

Advertisement